Taliaz / predictix

Taliaz is a personalized medicine company that has developed PREDICTIX, a highly-accurate decision support tool, to help clinicians identify the right treatment for their individual patients sooner. Addressing the multi-billion dollar personalized medicine market, our proprietary technology uses Big Data analytics and machine learning approaches, to design unique prediction algorithms. The PREDICTIX algorithm go beyond traditional genetic testing, by holistically understanding patients'​ unique genetic code, alongside their clinical history and demographic data. With this new level of clinical predictions, we can help improve patients’ quality of life and reduce the number of patients dropping out of treatment. Our flagship product, PREDICTIX Antidepressant, targets the depression market, where currently 65% of patients fail to achieve remission after their first antidepressant treatment! Additional products in development will address the wider, high-growth neuroscience market, with the platform technology customizable for any disease area. Using PREDICTIX's automated software service, DNA labs can provide a new standard in personalized medicine solutions and increase revenues. Our technology can also help pharmaceutical companies improve clinical trial success, by designing trials with those patients who are most likely to respond to treatment.